[Infections caused by beta-lactam resistant staphylococci on joint prostheses: diagnosis and treatment].
Muñoz
P
P
Servicio de Microbiología y Enfermedades Infecciosas-VIH, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid.
Bouza
E
E
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D001174:Arthrodesis; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects*; D007720:Knee Prosthesis / Q000009:adverse effects; D010019:Osteomyelitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D011379:Prognosis; D011446:Prospective Studies; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D012086:Reoperation; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D013211:Staphylococcus aureus; D013212:Staphylococcus epidermidis; D017334:Teicoplanin / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use; D018440:beta-Lactam Resistance
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D017334:Teicoplanin; D014640:Vancomycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D012293:Rifampin